Package Label.Principal Display Panel
NDC 70771-1675-3
Topiramate Extended-Release Capsules, 200 mg
30 Capsules
Rx only
200 mg Label (9e6d16a4 7328 4eb5 Ba5f Bd84fa0aef38 01)
Topiramate
FDA Label NDC 70771-1675
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Topiramate (NDC 70771-1675). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
* Please review the disclaimer below.
